Protagonist Therapeutics, Inc Adjustments to Additional Paid in Capital, Warrant Issued
Protagonist Therapeutics, Inc (PTGX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $33.81 million for the 12-month period ending 2023-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-02-25
- Protagonist Therapeutics, Inc adjustments to additional paid in capital, warrant issued for the quarter ending 2023-12-31 was $0.00.
- Protagonist Therapeutics, Inc adjustments to additional paid in capital, warrant issued for the quarter ending 2023-09-30 was $33.81M.
- Protagonist Therapeutics, Inc adjustments to additional paid in capital, warrant issued for fiscal 2023 was $33.81M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $33.81M derived: sum of 2 quarters · filed 2026-02-25 | $33.81M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $33.81M 10-Q · filed 2024-11-07 | $33.81M 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |